Significance of data analysis in the quality control of prenatal screening for Down syndrome

被引:7
|
作者
Li, Yahong [1 ]
Zhang, Xiaojuan [1 ]
Hong, Dongyang [1 ]
Guan, Xianwei [1 ]
Lv, Shaolei [2 ]
Sun, Yun [1 ]
Jiang, Tao [1 ]
机构
[1] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Ctr Prenatal Diag, Affiliated Obstet & Gynecol Hosp, 123 Tianfei Rd, Nanjing 210004, Jiangsu, Peoples R China
[2] Zhejiang Biosan Biochem Technol Co Ltd, Hangzhou 310000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
quality control; prenatal screening; Down syndrome;
D O I
10.3892/br.2018.1078
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dual detection of alpha-fetoprotein (AFP) and free beta-human chorionic gonadotropin (beta-HCG) is a common screening method for Down syndrome in the second trimester and its efficacy is assessed by false-positive rate (FPR). The present study aimed to investigate the effects of the bias in median multiple of the median (mMoM) values of AFP and free beta-HCG on FPR. The bias in mMoM values of AFP and free beta-HCG and the bias in mMoM values under different gestational ages and weight groups were analyzed. Median equations were adjusted, and medians in LifeCycle software were replaced by local medians. Following two adjustments of the median equations, all indices including FPR, mMoM values of markers and mMoM values under different gestational ages and weight groups generally reached an ideal state. In conclusion, abnormal bias in mMoM values may prompt aberrant application of median equations, and regular monitoring of these indicators may be important for quality control in prenatal screening.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 50 条
  • [1] Analysis of External Quality Assessment of Maternal Serum Prenatal Screening for Down Syndrome in the First Trimester in China
    He, Falin
    Wang, Wei
    Zhong, Kun
    Yuan, Shuai
    Du, Yuxuan
    Wang, Zhiguo
    CLINICAL LABORATORY, 2021, 67 (06) : 1357 - 1364
  • [2] Serological prenatal screening and diagnosis for Down syndrome
    Duan, Y.
    Li, Y.
    Xue, Q.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2014, 41 (05) : 572 - 574
  • [3] Uptake of prenatal diagnostic testing and the effectiveness of prenatal screening for Down syndrome
    Jaques, Alice M.
    Collins, Veronica R.
    Muggli, Evelyne E.
    Amor, David J.
    Francis, Ivan
    Sheffield, Leslie J.
    Halliday, Jane L.
    PRENATAL DIAGNOSIS, 2010, 30 (06) : 522 - 530
  • [4] Economic analysis of prenatal screening strategies for Down syndrome in singleton pregnancies in Turkey
    Okem, Zeynep Culdem
    Orgul, Gokcen
    Kasnakoglu, Berna Tari
    Cakar, Mehmet
    Beksac, M. Sinan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 219 : 40 - 44
  • [5] Analysis of Down syndrome failed to be diagnosed after prenatal screening A multicenter study
    Jiang, Tao
    Ding, Jie
    Zhang, Xiao-Qing
    Zhang, Xiao-Juan
    Zhang, Bin
    Wang, Ting
    Yu, Bin
    MEDICINE, 2017, 96 (24)
  • [6] Quality assurance of nuchal translucency for prenatal fetal Down syndrome screening
    Sahota, Daljit Singh
    Leung, Wing Cheong
    To, Wing Kee
    Chan, Wing Pan
    Lau, Tze Kin
    Leung, Tak Yeung
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (07) : 1039 - 1043
  • [7] Prenatal Screening for Down Syndrome in Australia
    Nisbet, Debbie L.
    McLennan, Andrew
    ULTRASOUND, 2009, 17 (03) : 167 - 170
  • [8] The Portrayal of Down Syndrome in Prenatal Screening Information Pamphlets
    Lawson, Karen L.
    Carlson, Kara
    Shynkaruk, Jody M.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2012, 34 (08) : 760 - 768
  • [9] Economic evaluation of prenatal screening for Down syndrome in the USA
    Beazoglou, T
    Heffley, D
    Kyriopoulos, J
    Vintzileos, A
    Benn, P
    PRENATAL DIAGNOSIS, 1998, 18 (12) : 1241 - 1252
  • [10] Circulating MicroRNAs in the Screening of Prenatal Down Syndrome
    Balci, Senay
    Cayan, Filiz
    Ozdemir, Gurbet Dogru
    Ay, Mustafa Ertan
    Yildirim, Didem Derici
    Tamer, Lulufer
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2023, 42 (03) : 219 - 225